Class Actions and Mass Torts in Personal Injury Law
Class actions and mass torts represent two distinct procedural frameworks that allow large numbers of injured plaintiffs to pursue claims arising from a common defendant or shared harmful conduct. Both mechanisms exist at the intersection of personal injury law and federal civil procedure, though they operate under different rules and produce different outcomes for individual claimants. Understanding how these two frameworks differ — and when each applies — is foundational to understanding large-scale litigation in the United States.
Definition and scope
A class action is a single lawsuit filed by one or more named plaintiffs on behalf of a defined group, called a "class," whose members share sufficiently uniform claims that individual trials would be impractical. The procedural authority for federal class actions is Federal Rule of Civil Procedure 23 (FRCP Rule 23), administered through the federal courts. Rule 23 requires a court to certify the class before litigation proceeds, evaluating four threshold criteria: numerosity, commonality, typicality, and adequacy of representation.
A mass tort, by contrast, consolidates large numbers of individually filed claims involving common facts — typically the same product, drug, or environmental event — but preserves each plaintiff's right to a separate verdict and individualized damages. Mass torts frequently proceed as Multidistrict Litigation (MDL) under 28 U.S.C. § 1407, which allows a Judicial Panel on Multidistrict Litigation (JPML) to transfer related federal cases to a single district for coordinated pretrial proceedings.
The scope distinction is significant: class actions typically resolve all claims through a single judgment binding on every class member, while mass tort MDL plaintiffs retain individual claims and receive separate damage awards. Product liability claims and pharmaceutical injury cases are the most common contexts where this distinction shapes litigation strategy.
How it works
Class Action Process under FRCP Rule 23
- Filing and class definition — A named plaintiff files a complaint defining a proposed class by geographic region, time period, type of injury, or exposure to a specific product or practice.
- Class certification motion — Plaintiffs move for certification, supported by expert evidence and statistical data. The court evaluates the four Rule 23(a) factors plus one of three Rule 23(b) categories (injunctive relief, common questions predominate, or limited fund).
- Notice to class members — If certified, absent class members receive court-approved notice and an opportunity to opt out in Rule 23(b)(3) actions.
- Discovery and merits litigation — Discovery proceeds on a class-wide basis, often involving expert witnesses to establish general causation.
- Settlement or trial — Most class actions settle. Court approval of any settlement is mandatory under Rule 23(e), requiring a finding that the settlement is "fair, reasonable, and adequate."
- Distribution — Settlement funds are distributed by a claims administrator according to a court-approved allocation plan.
Mass Tort MDL Process under 28 U.S.C. § 1407
The JPML consolidates cases before a single transferee judge for pretrial coordination. Bellwether trials — a small set of representative individual cases tried to verdict — are used to assess litigation value and drive global settlement negotiations. Each plaintiff retains a separate docket entry and individual damages determination. Cases that do not settle are remanded to their original districts for trial under the federal tort claims framework or applicable state law.
Causation standards are litigated differently across these two frameworks: class actions require proof of general causation applicable to the whole class, while mass torts may require each plaintiff to establish specific causation independently.
Common scenarios
Pharmaceutical and medical device litigation is the dominant mass tort category. MDL proceedings have addressed opioid manufacturer liability, transvaginal mesh injuries, and defective hip implants. As of the U.S. Courts' statistical reporting, MDL cases constituted approximately 67 percent of all pending federal civil cases in fiscal year 2022 (U.S. Courts, Judicial Business 2022).
Consumer product defect cases — including contaminated food, defective vehicles, and toxic household products — frequently qualify for class treatment when economic harm is uniform and individual damages are modest. The landmark tobacco litigation of the 1990s produced both class action attempts and large individual mass tort recoveries.
Environmental exposure claims arising from industrial pollution, contaminated water supplies, or hazardous waste sites are often structured as mass torts rather than class actions because plaintiffs' injuries differ in type and severity based on duration of exposure and proximity to the source. Strict liability theories apply in many such cases.
Securities and consumer fraud are primarily class action domains where Rule 23(b)(3) certification is common, given uniform per-share or per-transaction harm. These overlap with personal injury law only when physical harm accompanies financial loss.
Decision boundaries
The threshold question in large-scale litigation is whether the claims share enough legal and factual uniformity for class certification or whether individual differences predominate, making mass tort MDL the more appropriate vehicle.
| Factor | Class Action | Mass Tort MDL |
|---|---|---|
| Individual damage variation | Low | High |
| Causation uniformity | Required | Variable per plaintiff |
| Binding outcome | Yes — all class members | No — individual verdicts |
| Opt-out right | Yes (Rule 23(b)(3)) | Not applicable — each plaintiff controls claim |
| Governing procedure | FRCP Rule 23 | 28 U.S.C. § 1407 |
Damage caps imposed by state statutes can affect recovery differently depending on which framework applies, since class settlements must pass court scrutiny while individual mass tort verdicts are subject to standard post-trial review. Punitive damages in mass torts are litigated on an individual basis and assessed under the due process framework established in BMW of North America, Inc. v. Gore, 517 U.S. 559 (1996) (Cornell LII summary).
Statutes of limitations present distinct risks in both frameworks. Class action filing tolls the limitations period for absent class members under the doctrine established in American Pipe & Construction Co. v. Utah, 414 U.S. 538 (1974). In mass torts, each plaintiff's individual statute of limitations runs independently, and late-filing plaintiffs may be barred even if MDL coordination is ongoing.
References
- Federal Rule of Civil Procedure 23 — Cornell Legal Information Institute
- 28 U.S.C. § 1407 — Multidistrict Litigation (U.S. House Office of the Law Revision Counsel)
- Judicial Panel on Multidistrict Litigation — United States Courts
- U.S. Courts, Judicial Business 2022 — Civil Cases Statistical Tables
- BMW of North America, Inc. v. Gore, 517 U.S. 559 (1996) — Cornell LII
- American Pipe & Construction Co. v. Utah, 414 U.S. 538 (1974) — Cornell LII